A bitter pill

The Japanese courts recently vetoed a drug company's efforts to stop generic rivals from selling their products in lookalike packaging. John Tessensohn and Shusaku Yamamoto explain what the trade dress decision means for the pharmaceutical industry in one of the world's most lucrative drugs markets